{"id":"W2776594178","doi":"10.1016/j.clgc.2017.12.012","title":"Clinical Outcomes of First-line Abiraterone Acetate or Enzalutamide for Metastatic Castration-resistant Prostate Cancer After Androgen Deprivation Therapy + Docetaxel or ADT Alone for Metastatic Hormone-sensitive Prostate Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Enzalutamide; Medicine; Prostate cancer; Abiraterone acetate; Docetaxel; Androgen deprivation therapy; Oncology; Internal medicine; Cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001816091,0.0008010984,0.002559407,0.0001745685,0.0006408819,0.0001520723,0.0004543301,0.0002566379,0.0002542386],"category_scores_gemma":[0.001142668,0.0004955778,0.0009506263,0.0002603624,0.001033674,0.0005652482,0.000190109,0.0005547305,0.000008889376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003590053,"about_ca_system_score_gemma":0.002318997,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009249221,"about_ca_topic_score_gemma":0.00435623,"domain_scores_codex":[0.993656,0.0003207222,0.002734512,0.001394912,0.0007543031,0.001139519],"domain_scores_gemma":[0.9929104,0.00193284,0.001697295,0.001205221,0.001643984,0.0006102656],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3492263,0.003997463,0.4651011,0.002336138,0.01127302,0.001034959,0.001332468,0.000307356,0.004420817,0.000007880941,0.003809904,0.1571526],"study_design_scores_gemma":[0.09635057,0.01845702,0.835981,0.001396717,0.004961459,0.00004275777,0.0005370554,0.002261366,0.01984339,0.0005196092,0.01814885,0.00150026],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9645467,0.01128167,0.0002305266,0.007431103,0.001086208,0.009951117,0.005383409,0.0000732263,0.00001602888],"genre_scores_gemma":[0.8844092,0.08449872,0.006349253,0.0009672489,0.0009909776,0.01246084,0.0003208933,0.0002047713,0.009798069],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3708798,"threshold_uncertainty_score":0.9997496,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1838484741230866,"score_gpt":0.4752861645697759,"score_spread":0.2914376904466893,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}